News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
236,080 Results
Type
Article (5128)
Company Profile (17)
Press Release (230935)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (82278)
Career Advice (464)
Deals (15064)
Drug Delivery (9)
Drug Development (19082)
Employer Resources (30)
FDA (3685)
Job Trends (3922)
News (120230)
Policy (7510)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (303)
Accelerated approval (10)
ADA (11)
Adcomms (4)
Allergies (26)
Alliances (14809)
ALS (54)
Alzheimer's disease (338)
Antibody-drug conjugate (ADC) (80)
Approvals (3848)
Artificial intelligence (144)
ASCO (48)
Autoimmune disease (70)
Automation (14)
Bankruptcy (97)
Best Places to Work (2864)
BIO (20)
Biosimilars (42)
Biotechnology (19)
Bladder cancer (45)
Brain cancer (16)
Breast cancer (132)
Cancer (1198)
Cardiovascular disease (87)
Career advice (398)
Career pathing (5)
CAR-T (79)
CDC (3)
Celiac Disease (1)
Cell therapy (210)
Cervical cancer (10)
Clinical research (17132)
Collaboration (495)
Compensation (487)
Complete response letters (14)
COVID-19 (316)
CRISPR (19)
C-suite (513)
Cystic fibrosis (28)
Data (1899)
Denatured (2)
Depression (27)
Dermatology (24)
Diabetes (118)
Diagnostics (2206)
Digital health (14)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (53)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (52)
Earnings (43919)
Editorial (5)
Employer branding (6)
Employer resources (33)
Events (39976)
Executive appointments (499)
FDA (4604)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (426)
Gene editing (32)
Generative AI (7)
Gene therapy (127)
GLP-1 (163)
Government (440)
Guidances (207)
Healthcare (5121)
Hematology (51)
HIV (15)
Huntington's disease (10)
IgA nephropathy (19)
Immunology and inflammation (49)
Immuno-oncology (19)
Indications (39)
Infectious disease (355)
Inflammatory bowel disease (39)
Inflation Reduction Act (3)
Influenza (11)
Intellectual property (39)
Interviews (53)
IPO (7892)
IRA (3)
Job creations (1124)
Job search strategy (361)
JPM (4)
Kidney cancer (15)
Labor market (14)
Layoffs (112)
Leadership (7)
Legal (2338)
Liver cancer (22)
Longevity (4)
Lung cancer (133)
Lymphoma (94)
Machine learning (10)
Management (10)
Manufacturing (224)
Marketing (1)
MASH (64)
Medical device (3949)
Medtech (3990)
Mergers & acquisitions (7668)
Metabolic disorders (306)
mRNA (17)
Multiple sclerosis (24)
NASH (6)
Neurodegenerative disease (83)
Neuropsychiatric disorders (13)
Neuroscience (679)
NextGen: Class of 2026 (1676)
Non-profit (735)
Now hiring (7)
Obesity (121)
Opinion (35)
Ovarian cancer (46)
Pain (32)
Pancreatic cancer (66)
Parkinson's disease (76)
Partnered (6)
Patents (66)
Patient recruitment (152)
Peanut (6)
People (25671)
Pharmaceutical (6)
Pharmacy benefit managers (2)
Phase 1 (5128)
Phase 2 (7455)
Phase 3 (5941)
Pipeline (3394)
Policy (26)
Postmarket research (625)
Preclinical (1981)
Press Release (66)
Prostate cancer (75)
Psychedelics (3)
Radiopharmaceuticals (132)
Rare diseases (246)
Real estate (1892)
Recruiting (9)
Regulatory (5780)
Reports (18)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (30)
RNA editing (2)
RSV (2)
Schizophrenia (60)
Series A (74)
Series B (69)
Sickle cell disease (19)
Special edition (1)
Spinal muscular atrophy (37)
Sponsored (5)
Startups (1020)
Stomach cancer (1)
Supply chain (19)
Tariffs (7)
The Weekly (1)
Vaccines (99)
Venture capital (17)
Weight loss (44)
Women's health (11)
Worklife (1)
Date
Today (12)
Last 7 days (99)
Last 30 days (543)
Last 365 days (8954)
2026 (4837)
2025 (9038)
2024 (11028)
2023 (13196)
2022 (18665)
2021 (19680)
2020 (18242)
2019 (13207)
2018 (10203)
2017 (10001)
2016 (9156)
2015 (12117)
2014 (9588)
2013 (7707)
2012 (8331)
2011 (8797)
2010 (8634)
Location
Africa (186)
Alabama (20)
Alaska (2)
Arizona (82)
Arkansas (2)
Asia (11959)
Australia (1730)
California (4424)
Canada (1369)
China (232)
Colorado (175)
Connecticut (217)
Delaware (86)
Europe (26168)
Florida (679)
Georgia (92)
Idaho (24)
Illinois (213)
India (28)
Indiana (141)
Iowa (9)
Japan (240)
Kansas (43)
Kentucky (19)
Louisiana (11)
Maine (57)
Maryland (421)
Massachusetts (3623)
Michigan (109)
Minnesota (233)
Mississippi (1)
Missouri (40)
Montana (18)
Nebraska (12)
Nevada (55)
New Hampshire (16)
New Jersey (1276)
New Mexico (5)
New York (1011)
North Carolina (590)
North Dakota (5)
Northern California (2360)
Ohio (144)
Oklahoma (5)
Oregon (7)
Pennsylvania (761)
Puerto Rico (3)
Rhode Island (20)
South America (280)
South Carolina (19)
Southern California (1683)
Tennessee (78)
Texas (641)
United States (15481)
Utah (147)
Vermont (1)
Virginia (112)
Washington D.C. (17)
Washington State (387)
West Virginia (2)
Wisconsin (72)
Wyoming (1)
236,080 Results for "cambrex corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
July 7, 2026
·
2 min read
Press Releases
Cambrex Advances US and European Expansions
March 23, 2026
·
2 min read
Press Releases
Cambrex Announces Cornell Professor Song Lin as Recipient of the 2025 Snapdragon Prize for Innovation in Chemistry Technology
February 19, 2026
·
2 min read
Press Releases
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts
August 25, 2025
·
3 min read
Press Releases
Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience
October 22, 2025
·
2 min read
Press Releases
Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply
June 25, 2025
·
6 min read
Pharm Country
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule
Cambrex, a leading global contract development and manufacturing organization, announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.
March 18, 2024
·
2 min read
Pharm Country
Cambrex Announces Sale of Drug Product Business Unit
Cambrex, a leading global contract development and manufacturing organization, has completed the sale of its Drug Product Business Unit to Wilmington, Delaware based Noramco.
November 2, 2023
·
1 min read
Press Releases
Britannia Life Sciences Provides Corporate Update
Corporate Treasury Positioned with Cash and Liquid Equity Holdings to Seed, Incubate and Accelerate New and Existing Operations
May 21, 2026
·
4 min read
Deals
Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
Noramco, a leading global active pharmaceutical ingredients manufacturer, specializing in controlled substances, announced it has completed the acquisition of the Cambrex Drug Product Business Unit previously known as Halo Pharmaceuticals.
November 2, 2023
·
2 min read
1 of 23,608
Next
